Mankind Pharma and Innovent Biologics Partner to Revolutionize Cancer Care in India
Mankind Pharma and Innovent Biologics have announced a groundbreaking partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy,
Read More